CardioGen-82 (Bracco Diagnostics Inc)
Welcome to the PulseAid listing for the CardioGen-82 drug offered from Bracco Diagnostics Inc. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bracco Diagnostics Inc |
NON-PROPRIETARY NAME: | Rubidium Chloride RB-82 |
SUBSTANCE NAME: | RUBIDIUM CHLORIDE RB-82 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1989-12-30 |
END MARKETING DATE: | 0000-00-00 |
CardioGen-82 HUMAN PRESCRIPTION DRUG Details:
Item Description | CardioGen-82 from Bracco Diagnostics Inc |
LABELER NAME: | Bracco Diagnostics Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mCi/1) |
START MARKETING DATE: | 1989-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0270-0091_b51739a7-f4a7-4c3f-af96-6b75d661bf41 |
PRODUCT NDC: | 0270-0091 |
APPLICATION NUMBER: | NDA019414 |
Other RUBIDIUM CHLORIDE RB-82 Pharmaceutical Manufacturers / Labelers: